Moreover, cell cycle analysis showed that inhibition of IGF2BP3 in AML cells increased the proportion of G1-phase cells and decreased the proportion of G2-phase cells (Fig. 2g). Here, IGF2BP3 is linked to acute myeloid leukemia.